Funding opportunities We are constantly looking to fund research into developing new treatments and potential cures for AKU. The majority of our research is conducted in partnership with the University of Liverpool as well as a number of international partners. Below...
Diagnosis The diagnosis of AKU is made upon the identification of characteristic symptoms, patient history, and clinical evaluation. Identification of elevated levels of homogentisic acid (HGA) in the urine is indicative of AKU. AKU should be suspected of all...
Treatment AKU can be treated using the drug nitisinone. Our seven year DevelopAKUre study, which concluded in 2020, illustrated nitisinone effectively halts the build of homogentisic acid (HGA) by 99%. Nitisinone received a marketing authorisation from the European...
Get Involved Volunteer or Fundraise for the AKU Society We are always looking for volunteers to help support our mission of improving the lives of all those living with AKU and their loved ones. By supporting us with your time and talents, you can make a direct impact...
AKU Research Bursary Award We are pleased to announce that we are launching a bursary scheme for scientific research into alkaptonuria (AKU). Designed to support early-stage researchers who are committed to advancing our understanding of AKU, successful applicants...
